Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3441 Management of type-I gastric neuroendocrine neoplasms: A single center’s real world experience

Introduction: Currently, the optimal management of Type-1 gastric neuroendocrine neoplasms (T1gNENs) remains an active issue. The best endoscopic approach still needs to be defined.

Conference:

Presenting Author: Rinzivillo M

Authors: Rinzivillo M, Cazzato M, Esposito G, Lorenzi C, Pilozzi E,

Keywords: gastric neuroendocrine tumor, endoscopic resection,

#3170 Endoscopic resectability and clinical outcome of patients with rectal neuroendocrine neoplasms

Introduction: Rectal neuroendocrine neoplasms (rectal carcinoids or r-NEN) are lesions of uncertain malignant potential. Most of them are polypoid, with yellowish coloration, central ulceration and/or depression, or submucosal bulging, commonly measure less than 10 mm. Their finding is often incidental and are mainly asymptomatic. The most appropriate clinical and endoscopic management of these lesions is still debated.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Orlando D

Authors: Orlando D, Rinzivillo M, Magi L, Angeletti S, Pilozzi E,

Keywords: rectal neuroendocrine neoplasm, endoscopic resection, rectum,

#2785 Inhibition of Cyclin Dependent Kinases Overcomes MYC-Driven Secondary Resistance to Everolimus in Digestive NETs

Introduction: Dysregulation of the mTOR pathway in digestive neuroendocrine tumours (d-NETs) led to the introduction of Everolimus (EVE) as treatment. EVE significantly increases PFS, but most patients acquire resistance, due to activation of feedback loops.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Capurso G

Authors: Terracciano F, Capone A, Montori A, Pilozzi E, Arcidiacono P,

Keywords: mTOR, Myc, resistance, pathway, RNA-seq,